AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
PROPERTIES OF HIV ENVELOPE EXPRESSED IN THE PRESENCE OF SPC3, AN ENV-DERIVED PEPTIDE DRUG UNDER PHASE-II CLINICAL-TRIALS
Authors: BARBOUCHE R FENOUILLET E PAPANDREOU MJ KIENY MP SABATIER JM
Citation: R. Barbouche et al., PROPERTIES OF HIV ENVELOPE EXPRESSED IN THE PRESENCE OF SPC3, AN ENV-DERIVED PEPTIDE DRUG UNDER PHASE-II CLINICAL-TRIALS, The journal of peptide research, 52(4), 1998, pp. 283-288
PRODUCTION OF CHOLERA-TOXIN-B SUBUNIT IN LACTOBACILLUS
Authors: SLOS P DUTOT P REYMUND J KLEINPETER P PROZZI D KIENY MP DELCOUR J MERCENIER A HOLS P
Citation: P. Slos et al., PRODUCTION OF CHOLERA-TOXIN-B SUBUNIT IN LACTOBACILLUS, FEMS microbiology letters, 169(1), 1998, pp. 29-36
RESTRICTED SPECIFICITY OF ANTI-V3 ANTIBODIES INDUCED IN HUMANS BY HIVCANDIDATE VACCINES
Authors: COEFFIER E EXCLER JL KIENY MP MEIGNIER B MOSTE C TARTAGLIA J PIALOUX G SALMONCERON D LECLERC C
Citation: E. Coeffier et al., RESTRICTED SPECIFICITY OF ANTI-V3 ANTIBODIES INDUCED IN HUMANS BY HIVCANDIDATE VACCINES, AIDS research and human retroviruses, 13(17), 1997, pp. 1471-1485
PROTECTION OF SIVMAC-INFECTED MACAQUE MONKEYS AGAINST SUPERINFECTION BY A SIMIAN IMMUNODEFICIENCY VIRUS EXPRESSING ENVELOPE GLYCOPROTEINS OF HIV TYPE-1
Authors: DUNN CS HURTREL B BEYER C GLOECKLER L LEDGER TN MOOG C KIENY MP MEHTALI M SCHMITT D GUT JP KIRN A AUBERTIN AM
Citation: Cs. Dunn et al., PROTECTION OF SIVMAC-INFECTED MACAQUE MONKEYS AGAINST SUPERINFECTION BY A SIMIAN IMMUNODEFICIENCY VIRUS EXPRESSING ENVELOPE GLYCOPROTEINS OF HIV TYPE-1, AIDS research and human retroviruses, 13(11), 1997, pp. 913-922
SELF-ASSOCIATION OF TRUNCATED FORMS OF HIV-1 GP120
Authors: MALVOISIN E KIENY MP WILD F
Citation: E. Malvoisin et al., SELF-ASSOCIATION OF TRUNCATED FORMS OF HIV-1 GP120, Virus research, 49(2), 1997, pp. 163-172
CYP7B, A NOVEL BRAIN CYTOCHROME-P450, CATALYZES THE SYNTHESIS OF NEUROSTEROIDS 7-ALPHA-HYDROXY DEHYDROEPIANDROSTERONE AND 7-ALPHA-HYDROXY PREGNENOLONE
Authors: ROSE KA STAPLETON G DOTT K KIENY MP BEST R SCHWARZ M RUSSELL DW BJORKHEM I SECKL J LATHE R
Citation: Ka. Rose et al., CYP7B, A NOVEL BRAIN CYTOCHROME-P450, CATALYZES THE SYNTHESIS OF NEUROSTEROIDS 7-ALPHA-HYDROXY DEHYDROEPIANDROSTERONE AND 7-ALPHA-HYDROXY PREGNENOLONE, Proceedings of the National Academy of Sciences of the United Statesof America, 94(10), 1997, pp. 4925-4930
ANTIPLATELET ANTIBODIES DURING THE COURSE OF HIV-PREVENTIVE VACCINE TRIAL
Authors: KAPLAN C MORELKOPP MC KIENY MP KOLBE H SALMON D SICARD D PIALOUX G MEIGNIER B EXCLER JL PLOTKIN S
Citation: C. Kaplan et al., ANTIPLATELET ANTIBODIES DURING THE COURSE OF HIV-PREVENTIVE VACCINE TRIAL, AIDS, 10(4), 1996, pp. 447-449
HIGH VIRAL LOAD AND CD4 LYMPHOPENIA IN RHESUS AND CYNOMOLGUS MACAQUESINFECTED BY A CHIMERIC PRIMATE LENTIVIRUS CONSTRUCTED USING THE ENV, REV, TAT, AND VPU GENES FROM HIV-1 LAI
Authors: DUNN CS BEYER C KIENY MP GLOECKLER L SCHMITT D GUT JP KIRN A AUBERTIN AM
Citation: Cs. Dunn et al., HIGH VIRAL LOAD AND CD4 LYMPHOPENIA IN RHESUS AND CYNOMOLGUS MACAQUESINFECTED BY A CHIMERIC PRIMATE LENTIVIRUS CONSTRUCTED USING THE ENV, REV, TAT, AND VPU GENES FROM HIV-1 LAI, Virology, 223(2), 1996, pp. 351-361
DIVERSITY OF THE ENVELOPE GLYCOPROTEIN AMONG HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES OF CLADE-E FROM ASIA AND AFRICA
Authors: MCCUTCHAN FE ARTENSTEIN AW SANDERSBUELL E SALMINEN MO CARR JK MASCOLA JR YU XF NELSON KE KHAMBOONRUANG C SCHMITT D KIENY MP MCNEIL JG BURKE DS
Citation: Fe. Mccutchan et al., DIVERSITY OF THE ENVELOPE GLYCOPROTEIN AMONG HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES OF CLADE-E FROM ASIA AND AFRICA, Journal of virology, 70(6), 1996, pp. 3331-3338
MEMORY CYTOTOXIC T-LYMPHOCYTE RESPONSES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I (HIV-1)-NEGATIVE VOLUNTEERS IMMUNIZED WITH A RECOMBINANT CANARYPOX EXPRESSING GP160 OF HIV-1 AND BOOSTED WITH A RECOMBINANT GP160
Authors: FLEURY B JANVIER G PIALOUX G BUSEYNE F ROBERTSON MN TARTAGLIA J PAOLETTI E KIENY MP EXCLER JL RIVIERE Y
Citation: B. Fleury et al., MEMORY CYTOTOXIC T-LYMPHOCYTE RESPONSES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I (HIV-1)-NEGATIVE VOLUNTEERS IMMUNIZED WITH A RECOMBINANT CANARYPOX EXPRESSING GP160 OF HIV-1 AND BOOSTED WITH A RECOMBINANT GP160, The Journal of infectious diseases, 174(4), 1996, pp. 734-738
IMMUNOGENICITY OF HIV-1(LAI) GP160 AND ENV PEPTIDES IN SQUIRREL-MONKEY SAIMIRI-SCIUREUS USING ALUMINE AND EXPERIMENTAL ADJUVANTS
Authors: PERRAUT R CHOUTEAU P MOOG C BONNEMAINS B KIENY MP
Citation: R. Perraut et al., IMMUNOGENICITY OF HIV-1(LAI) GP160 AND ENV PEPTIDES IN SQUIRREL-MONKEY SAIMIRI-SCIUREUS USING ALUMINE AND EXPERIMENTAL ADJUVANTS, Clinical and experimental immunology, 106(3), 1996, pp. 434-441
HIV-1 RECOMBINANT POXVIRUS VACCINE INDUCES CROSS-PROTECTION AGAINST HIV-2 CHALLENGE IN RHESUS MACAQUES
Authors: ABIMIKU AG FRANCHINI G TARTAGLIA J ALDRICH K MYAGKIKH M MARKHAM PD CHONG PL KLEIN M KIENY MP PAOLETTI E GALLO RC ROBERTGUROFF M
Citation: Ag. Abimiku et al., HIV-1 RECOMBINANT POXVIRUS VACCINE INDUCES CROSS-PROTECTION AGAINST HIV-2 CHALLENGE IN RHESUS MACAQUES, Nature medicine, 1(4), 1995, pp. 321-329
A PRIME-BOOST APPROACH TO HIV PREVENTIVE VACCINE USING A RECOMBINANT CANARYPOX VIRUS EXPRESSING GLYCOPROTEIN-160 (MN) FOLLOWED BY A RECOMBINANT GLYCOPROTEIN-160 (MN LAI)/
Authors: PIALOUX G EXCLER JL RIVIERE Y GONZALEZCANALI G FEUILLIE V COULAUD P GLUCKMAN JC MATTHEWS TJ MEIGNIER B KIENY MP GONNET P DIAZ I MERIC C PAOLETTI E TARTAGLIA J SALOMON H PLOTKIN S
Citation: G. Pialoux et al., A PRIME-BOOST APPROACH TO HIV PREVENTIVE VACCINE USING A RECOMBINANT CANARYPOX VIRUS EXPRESSING GLYCOPROTEIN-160 (MN) FOLLOWED BY A RECOMBINANT GLYCOPROTEIN-160 (MN LAI)/, AIDS research and human retroviruses, 11(3), 1995, pp. 373-381
SAFETY AND IMMUNOGENICITY OF A RECOMBINANT HIV TYPE-1 GLYCOPROTEIN-160 BOOSTED BY A V3 SYNTHETIC PEPTIDE IN HIV-NEGATIVE VOLUNTEERS
Authors: SALMONCERON D EXCLER JL SICARD D BLANCHE P FINKIELSTZJEN L GLUCKMAN JC AUTRAN B MATTHEWS TJ MEIGNIER B KIENY MP VALENTIN C GONNET P DIAZ I SALOMON H PIALOUX G GONZALEZCANALI G PLOTKIN S
Citation: D. Salmonceron et al., SAFETY AND IMMUNOGENICITY OF A RECOMBINANT HIV TYPE-1 GLYCOPROTEIN-160 BOOSTED BY A V3 SYNTHETIC PEPTIDE IN HIV-NEGATIVE VOLUNTEERS, AIDS research and human retroviruses, 11(12), 1995, pp. 1479-1486
CYTOKINE GENE-THERAPY OF MURINE TUMORS USING RECOMBINANT VACCINIA VIRUS
Authors: ACRES B DOTT K STEFANI L BALLOUL JM KIENY MP
Citation: B. Acres et al., CYTOKINE GENE-THERAPY OF MURINE TUMORS USING RECOMBINANT VACCINIA VIRUS, Journal of cellular biochemistry, 1995, pp. 159-159
DEVELOPMENT OF LACTIC-ACID BACTERIA AS LIVE VECTORS FOR ORAL OR LOCALVACCINES
Authors: MERCENIER A SLOS P DUTOT P KLEINPETER P REYMUND J PARISCOUSSINIER P KIENY MP
Citation: A. Mercenier et al., DEVELOPMENT OF LACTIC-ACID BACTERIA AS LIVE VECTORS FOR ORAL OR LOCALVACCINES, Journal of cellular biochemistry, 1995, pp. 260-260
CLONED ANTIGENS AND ANTIIDIOTYPES
Authors: HERLYN D SOMASUNDARAM R ZALOUDIK J LI W JACOB L HARRIS D KIENY MP RICCIARDI R GONCZOL E SEARS H MASTRANGELO M
Citation: D. Herlyn et al., CLONED ANTIGENS AND ANTIIDIOTYPES, Hybridoma, 14(2), 1995, pp. 159-166
HETEROLOGOUS HIV-2 CHALLENGE OF RHESUS-MONKEYS IMMUNIZED WITH RECOMBINANT VACCINIA VIRUSES AND PURIFIED RECOMBINANT HIV-2 PROTEINS
Authors: VOGT G LEGRAND R VASLIN B BOUSSIN F AUBOYER MHB RIVIERE Y PUTKONEN P SONIGO P KIENY MP GIRARD M DORMONT D
Citation: G. Vogt et al., HETEROLOGOUS HIV-2 CHALLENGE OF RHESUS-MONKEYS IMMUNIZED WITH RECOMBINANT VACCINIA VIRUSES AND PURIFIED RECOMBINANT HIV-2 PROTEINS, Vaccine, 13(2), 1995, pp. 202-208
SINGLE PEPTIDE AND ANTIIDIOTYPE BASED IMMUNIZATIONS CAN BROADEN THE ANTIBODY-RESPONSE AGAINST THE VARIABLE V3 DOMAIN OF HIV-1 IN MICE
Authors: BOUDET F KELLER H KIENY MP THEZE J
Citation: F. Boudet et al., SINGLE PEPTIDE AND ANTIIDIOTYPE BASED IMMUNIZATIONS CAN BROADEN THE ANTIBODY-RESPONSE AGAINST THE VARIABLE V3 DOMAIN OF HIV-1 IN MICE, Molecular immunology, 32(7), 1995, pp. 449-457
VACCINE-INDUCED PROTECTION OF CHIMPANZEES AGAINST INFECTION BY A HETEROLOGOUS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
Authors: GIRARD M MEIGNIER B BARRESINOUSSI F KIENY MP MATTHEWS T MUCHMORE E NARA PL WEI Q RIMSKY L WEINHOLD K FULTZ PN
Citation: M. Girard et al., VACCINE-INDUCED PROTECTION OF CHIMPANZEES AGAINST INFECTION BY A HETEROLOGOUS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Journal of virology, 69(10), 1995, pp. 6239-6248
IMMUNOMODULATORY ACTIVITY OF MONOCLONAL ANTIIDIOTYPIC ANTIBODY TO ANTI-COLORECTAL CARCINOMA ANTIBODY-CO17-1A IN ANIMALS AND PATIENTS
Authors: HERLYN D HARRIS D ZALOUDIK J SPERLAGH M MARUYAMA H JACOB L KIENY MP SCHECK S SOMASUNDARAM R HART E ERTL H MASTRANGELO M
Citation: D. Herlyn et al., IMMUNOMODULATORY ACTIVITY OF MONOCLONAL ANTIIDIOTYPIC ANTIBODY TO ANTI-COLORECTAL CARCINOMA ANTIBODY-CO17-1A IN ANIMALS AND PATIENTS, Journal of immunotherapy with emphasis on tumor immunology, 15(4), 1994, pp. 303-311
RECOMBINANT CHOLERA-TOXIN B-SUBUNIT IN ESCHERICHIA-COLI - HIGH-LEVEL SECRETION, PURIFICATION, AND CHARACTERIZATION
Authors: SLOS P SPECK D ACCART N KOLBE HVJ SCHUBNEL D BOUCHON B BISCHOFF R KIENY MP
Citation: P. Slos et al., RECOMBINANT CHOLERA-TOXIN B-SUBUNIT IN ESCHERICHIA-COLI - HIGH-LEVEL SECRETION, PURIFICATION, AND CHARACTERIZATION, Protein expression and purification, 5(5), 1994, pp. 518-526
FEASIBILITY OF DEVELOPING LIVE ATTENUATED HIV VACCINES - CONCLUSIONS AND RECOMMENDATIONS
Authors: BALAYAN M BHAMARAPRAVATI N BURKE D CHANDLER DK DESROSIERS R SCHILD G SCHULTZ A SHAW GM STOTT J WEISS R WIGZELL H DOWDLE WR GIRARD M GOUDSMIT J GUIMARAES CS KIENY MP MBIDDE EK ROSCAMABBING EW ESPARZA J HEYMANN DL HEYWARD WL KALLINGS LO MERSON MH OSMANOV S SABA J
Citation: M. Balayan et al., FEASIBILITY OF DEVELOPING LIVE ATTENUATED HIV VACCINES - CONCLUSIONS AND RECOMMENDATIONS, AIDS research and human retroviruses, 10(2), 1994, pp. 221-222
ROLE OF HIV CYTOTOXIC EFFECTOR-CELLS IN DISEASE PROGRESSION
Authors: RIVIERE Y MCCHESNEY M PORROT F TANNEAU F BUSEYNE F REGNAULT A KOVARIK S SANSONETTI P LOPEZ O MOLLEREAU M PIALOUX G MARIE C CHAMARET S KIENY MP TEKAIA F MONTAGNIER L
Citation: Y. Riviere et al., ROLE OF HIV CYTOTOXIC EFFECTOR-CELLS IN DISEASE PROGRESSION, AIDS research and human retroviruses, 10, 1994, pp. 190000089-190000089
DIFFERENT APPROACHES TOWARDS AN HIV VACCINE USING SIV AS A MODEL
Authors: MEHTALI M BENAVENTE A SCHMITT D DOTT K BAYER C VENET A HURTREL B AUBERTIN AM KIENY MP
Citation: M. Mehtali et al., DIFFERENT APPROACHES TOWARDS AN HIV VACCINE USING SIV AS A MODEL, AIDS research and human retroviruses, 10, 1994, pp. 190000044-190000044
Risultati: 1-25 | 26-37